Plasma MIR-127 and MIR-218 might serve as potential biomarkers for cervical cancer

Reproductive Sciences

Volumn 22, Issue 8, 2015, Pages 1037-1041

  You, Weizhi ^a   Wang, Yugui ^a   Zheng, Jizeng ^b  

^a LIAOCHENG PEOPLE'S HOSPITAL   (China)

^b The Third People s Hospital of Liaocheng   (China)

Author keywords

cervical cancer; micro RNA; MIR 127; MIR 205; MIR 218; screening

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; MICRORNA; MICRORNA 127; MICRORNA 205; MICRORNA 218; UNCLASSIFIED DRUG; MIRN127 MICRORNA, HUMAN; MIRN205 MICRORNA, HUMAN; MIRN218 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER PATIENT; CANCER SCREENING; CANCER SIZE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CANCER; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; GENETICS; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; UTERINE CERVIX TUMOR;

ADULT; AREA UNDER CURVE; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; FEMALE; HUMANS; MICRORNAS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; ROC CURVE; UTERINE CERVICAL NEOPLASMS;

EID: 84937556423     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719115570902     Document Type: Article

References (31)

1. Cramer DW,. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer. 1974; 34 (6): 2018-2027.
2. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63 (1): 11-30.
3. Sheibani Kh M, Alidoosti A, Motlagh A,. Clinical manifestations and treatment results of patients with Cervical cancer: a report from Iran. Surgery. 2009; 209 (108): 108.
4. Moczko JA, Roszak A,. Application of mathematical modeling in survival time prediction for females with advanced cervical cancer treated radio-chemotherapy. Comput Meth Sci Technol. 2006; 12 (2): 143-147.
5. Yim EK, Park JS,. Biomarkers in cervical cancer. Biomarker Insights. 2006; 1: 215-225.
6. Saslow D, Solomon D, Lawson HW,. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012; 62 (3): 147-172.
7. Ichimi T, Enokida H, Okuno Y,. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer. 2009; 125 (2): 345-352.
8. Iorio MV, Ferracin M, Liu C-G,. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005; 65 (16): 7065-7070.
9. Ueda T, Volinia S, Okumura H,. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010; 11 (2): 136-146.
10. Yanaihara N, Caplen N, Bowman E,. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006; 9 (3): 189-198.
11. Lu J, Getz G, Miska EA,. MicroRNA expression profiles classify human cancers. Nature. 2005; 435 (7043): 834-838.
12. Zhang B, Pan X, Cobb GP, Anderson TA,. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007; 302 (1): 1-12.
13. Zen K, Zhang CY,. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev. 2012; 32 (2): 326-348.
14. Kosaka N, Iguchi H, Ochiya T,. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010; 101 (10): 2087-2092.
15. Zhang L, Huang J, Yang N,. microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci. 2006; 103 (24): 9136-9141.
16. Leite KR, Sousa-Canavez JM, Reis ST,. Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol. 2011; 29 (3): 265-269.
17. Lujambio A, Ropero S, Ballestar E,. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res. 2007; 67 (4): 1424-1429.
18. Saito Y, Liang G, Egger G,. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell. 2006; 9 (6): 435-443.
19. Gregory PA, Bert AG, Paterson EL,. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008; 10 (5): 593-601.
20. kenryu Nishiyama NS, Nakagawa M,. miR-218 on the genomic loss region of chromosome 4p15. 31 functions as a tumor suppressor in bladder cancer. Int J Oncol. 2011; 39 (1): 13-21.
21. Tie J, Pan Y, Zhao L,. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet. 2010; 6 (3): e1000879.
22. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics. 2002;(182): 17-23.
23. Gandellini P, Folini M, Longoni N,. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Cancer Res. 2009; 69 (6): 2287-2295.
24. Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES,. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008; 54 (10): 1696-704.
25. Wiklund ED, Bramsen JB, Hulf T,. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer. 2011; 128 (6): 1327-1334.
26. Iorio MV, Casalini P, Piovan C,. microRNA-205 regulates HER3 in human breast cancer. Cancer Res. 2009; 69 (6): 2195-2200.
27. Calin GA, Croce CM,. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006; 6 (11): 857-866.
28. Ando T, Yoshida T, Enomoto S,. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer. 2009; 124 (10): 2367-2374.
29. Catto JW, Miah S, Owen HC,. Distinct microRNA alterations characterize high-and low-grade bladder cancer. Cancer Res. 2009; 69 (21): 8472-8481.
30. Lee JW, Choi CH, Choi JJ,. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res. 2008; 14 (9): 2535-2542.
31. Reshmi G, Pillai MR,. Beyond HPV: oncomirs as new players in cervical cancer. FEBS Lett. 2008; 582 (30): 4113-4116.